Key facts
- It has raised $2.3M; the latest was Seed Round ($2.3M) in Feb 2025.
- Notable investors include Adverb Ventures, Springbank Collective, Esther Dyson, Coalition Operators.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Shotsy
- ·The full record, as it builds
Funding rounds
No funding rounds for Shotsy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shotsy
Developer of comprehensive tracking software intended to track GLP-1 medications with ease. The company's platform tracks weekly GLP-1 shots, side effects, and notes, syncs data for weight loss, and protein, and records injection sites and dosages, enabling users to keep track of medication progress.
- Sector
- Healthcare
- HQ
- Salem, OR, United States
- Founded
- 2024
- Website
- shotsyapp.com/
- Ownership
- Privately Held (backing)
Shotsy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shotsy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shotsy in its N-PORT filings yet. We sweep new filings monthly.